SOT Stock Overview
Societe de Therapeutique Marocaine S.A., a pharmaceutical company, manufactures and sells medicines in Morocco.
No risks detected for SOT from our risk checks.
Societe de Therapeutique Marocaine S.A. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||د.م1,445.00|
|52 Week High||د.م1,737.00|
|52 Week Low||د.م1,330.00|
|1 Month Change||-3.02%|
|3 Month Change||-3.73%|
|1 Year Change||-3.28%|
|3 Year Change||277.78%|
|5 Year Change||284.05%|
|Change since IPO||983.76%|
Recent News & Updates
|SOT||MA Pharmaceuticals||MA Market|
Return vs Industry: SOT exceeded the MA Pharmaceuticals industry which returned -28.5% over the past year.
Return vs Market: SOT exceeded the MA Market which returned -17.1% over the past year.
|SOT Average Weekly Movement||3.5%|
|Pharmaceuticals Industry Average Movement||4.3%|
|Market Average Movement||4.8%|
|10% most volatile stocks in MA Market||6.3%|
|10% least volatile stocks in MA Market||3.1%|
Stable Share Price: SOT is less volatile than 75% of MA stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SOT's weekly volatility (4%) has been stable over the past year.
About the Company
Societe de Therapeutique Marocaine S.A., a pharmaceutical company, manufactures and sells medicines in Morocco. It offers antibiotics; and allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, CNS, and urology, as well as other generic drugs. The company offers its products in various forms, such as tablets, capsules, pouches, syrups, suspensions, powders, collyriums, suppositories, creams and pomades, injectable solutions, and self-injectable syringes.
Societe de Therapeutique Marocaine S.A. Fundamentals Summary
|SOT fundamental statistics|
Is SOT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SOT income statement (TTM)|
|Cost of Revenue||د.م1.11b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||42.53|
|Net Profit Margin||13.71%|
How did SOT perform over the long term?See historical performance and comparison